Good Sense Acetaminophen Child Suspension Recalled Due to Contaminated Excipient
Perrigo is recalling Good Sense Pain and Fever acetaminophen child oral suspension (160mg/5ml, 4 FL OZ bottles) nationwide because the product was manufactured with a contaminated excipient that was recalled by the supplier.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as Class II. The source text does not report any illnesses, injuries, or deaths associated with the contaminated excipient, and the hazard is a manufacturing deviation without explicit identification of a specific harmful substance. This meets the threshold for Moderate severity.
Plain-English summary
Perrigo Company PLC is recalling Good Sense Pain and Fever Acetaminophen Child Dye Free Cherry Flavor Oral Suspension, 160mg/5ml, 4 FL OZ (118 mL) bottles, NDC 0113-8959-26. The recall affects 2,832 bottles with batch number 1BK1045 and expiration date 12/31/2022.
The product was manufactured with a contaminated excipient that was itself recalled by the excipient supplier. This represents a deviation from Good Manufacturing Practice (CGMP) standards.
The recalled product was distributed nationwide in the USA. Consumers who have purchased this product should stop use and contact Perrigo Company PLC with questions or concerns.
The recalled product
- Product
- GOOD SENSE PAIN AND FEVER (ACETAMINOPHEN)
- Brand
- GOOD SENSE PAIN AND FEVER
- Manufacturer
- Perrigo Company PLC
- Hazard
- contaminated-excipient
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 1BK1045
- Exp 12/31/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27